{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:23:31Z","timestamp":1792801411773,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","award":["DP5OD019833"],"award-info":[{"award-number":["DP5OD019833"]}],"id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["R01AG054671"],"award-info":[{"award-number":["R01AG054671"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["R01AG062559"],"award-info":[{"award-number":["R01AG062559"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["1F31AG062158-01A1"],"award-info":[{"award-number":["1F31AG062158-01A1"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["AG058805-01"],"award-info":[{"award-number":["AG058805-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["R01 AG031581, P30 AG19610"],"award-info":[{"award-number":["R01 AG031581, P30 AG19610"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["P01AG036694, P50AG005134, 2009-2020, and U19 AG10483"],"award-info":[{"award-number":["P01AG036694, P50AG005134, 2009-2020, and U19 AG10483"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Massachusetts General Hospital ECOR","award":["1200-228010 and 1200-228767"],"award-info":[{"award-number":["1200-228010 and 1200-228767"]}],"id":[{"id":"https:\/\/ror.org\/002pd6e78","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"crossref","award":["111565741185"],"award-info":[{"award-number":["111565741185"]}],"id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AACF_16-440965"],"award-info":[{"award-number":["AACF_16-440965"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","award":["ADRF A2016434F"],"award-info":[{"award-number":["ADRF A2016434F"]}],"id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","award":["Rappaport Fellowship"],"award-info":[{"award-number":["Rappaport Fellowship"]}],"id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010292","name":"Banner Alzheimer\u2019s Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010292","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008483","name":"NOMIS Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008483","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG027435, AG036694, R01 AG046396, R13 AG042201174210, and U01AG024904"],"award-info":[{"award-number":["R01 AG027435, AG036694, R01 AG046396, R13 AG042201174210, and U01AG024904"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Josephine and John Marr Alzheimer's Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neuroimaging studies of autosomal dominant Alzheimer\u2019s disease (ADAD) enable characterization of the trajectories of cerebral amyloid-\u03b2 (A\u03b2) and tau accumulation in the decades prior to clinical symptom onset. Longitudinal rates of regional tau accumulation measured with positron emission tomography (PET) and their relationship with other biomarker and cognitive changes remain to be fully characterized in ADAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Fourteen ADAD mutation carriers (\n                      <jats:italic>Presenilin-1<\/jats:italic>\n                      E280A) and 15 age-matched non-carriers from the Colombian kindred underwent 2\u20133 sessions of A\u03b2 (11C-Pittsburgh compound B) and tau (18F-flortaucipir) PET, structural magnetic resonance imaging, and neuropsychological evaluation over a 2\u20134-year follow-up period. Annualized rates of change for imaging and cognitive variables were compared between carriers and non-carriers, and relationships among baseline measurements and rates of change were assessed within carriers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Longitudinal measurements were consistent with a sequence of ADAD-related changes beginning with A\u03b2 accumulation (16\u2009years prior to expected symptom onset, EYO), followed by entorhinal cortex (EC) tau (9 EYO), neocortical tau (6 EYO), hippocampal atrophy (6 EYO), and cognitive decline (4 EYO). Rates of tau accumulation among carriers were most rapid in parietal neocortex (~\u20099%\/year). EC tau PET signal at baseline was a significant predictor of subsequent neocortical tau accumulation and cognitive decline within carriers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results are consistent with the sequence of biological changes in ADAD implied by cross-sectional studies and highlight the importance of EC tau as an early biomarker and a potential link between A\u03b2 burden and neocortical tau accumulation in ADAD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-020-00765-5","type":"journal-article","created":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T12:03:31Z","timestamp":1610712211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer\u2019s disease: findings from the Colombia-Boston (COLBOS) biomarker study"],"prefix":"10.1186","volume":"13","author":[{"given":"Justin S.","family":"Sanchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard J.","family":"Hanseeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Lopera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reisa A.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Baena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamile","family":"Bocanegra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Aguillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmarie","family":"Guzm\u00e1n-V\u00e9lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enmanuelle","family":"Pardilla-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Ramirez-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Vila-Castelar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo E.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua T.","family":"Fox-Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ochoa-Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi I. L.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron P.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Gatchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Alex","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha R.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle V.","family":"Mayblyum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Reiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakeel T.","family":"Quiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"issue":"9","key":"765_CR1","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1212\/WNL.42.9.1681","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada PV, Marzloff K, Hyman BT. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer\u2019s disease. Neurology. 1992;42(9):1681\u20138.","journal-title":"Neurology."},{"issue":"3","key":"765_CR2","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1212\/WNL.46.3.707","volume":"46","author":"JC Morris","year":"1996","unstructured":"Morris JC, Storandt M, McKeel DW Jr, Rubin EH, Price JL, Grant EA, et al. Cerebral amyloid deposition and diffuse plaques in \u201cnormal\u201d aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology. 1996;46(3):707\u201319.","journal-title":"Neurology."},{"issue":"3","key":"765_CR3","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.neuron.2014.10.038","volume":"84","author":"R Sperling","year":"2014","unstructured":"Sperling R, Mormino E, Johnson K. The evolution of preclinical Alzheimer\u2019s disease: implications for prevention trials. Neuron. 2014;84(3):608\u201322.","journal-title":"Neuron."},{"issue":"2","key":"765_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ng1095-219","volume":"11","author":"RF Clark","year":"1995","unstructured":"Clark RF, Hutton M, Fuldner M, Froelich S, Karran E, Talbot C, et al. The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. Nat Genet. 1995;11(2):219\u201322.","journal-title":"Nat Genet"},{"issue":"10","key":"765_CR5","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/nm1096-1146","volume":"2","author":"CA Lemere","year":"1996","unstructured":"Lemere CA, Lopera F, Kosik KS, Lendon CL, Ossa J, Saido TC, et al. The E280A presenilin 1 Alzheimer mutation produces increased A\u03b242 deposition and severe cerebellar pathology. Nat Med. 1996;2(10):1146\u201350.","journal-title":"Nat Med"},{"issue":"8","key":"765_CR6","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nm0896-864","volume":"2","author":"D Scheuner","year":"1996","unstructured":"Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, et al. Secreted amyloid \u03b2\u2013protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease. Nat Med. 1996;2(8):864\u201370.","journal-title":"Nat Med"},{"issue":"9","key":"765_CR7","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1093\/brain\/122.9.1709","volume":"122","author":"T G\u00f3mez-Isla","year":"1999","unstructured":"G\u00f3mez-Isla T, Growdon WB, McNamara MJ, Nochlin D, Bird TD, Arango JC, et al. The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer\u2019s disease brainEvidence for other phenotype-modifying factors. Brain. 1999;122(9):1709\u201319.","journal-title":"Brain."},{"issue":"2","key":"765_CR8","first-page":"112","volume":"6","author":"JT Fuller","year":"2019","unstructured":"Fuller JT, Cronin-Golomb A, Gatchel JR, Norton DJ, Guzman-Velez E, Jacobs HIL, et al. Biological and cognitive markers of Presenilin1 E280A autosomal dominant Alzheimer\u2019s disease: a comprehensive review of the Colombian kindred. J Prev Alzheimers Dis. 2019;6(2):112\u201320.","journal-title":"J Prev Alzheimers Dis"},{"issue":"9","key":"765_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med. 2012;367(9):795\u2013804.","journal-title":"N Engl J Med"},{"issue":"3","key":"765_CR10","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1001\/jamaneurol.2014.3314","volume":"72","author":"AS Fleisher","year":"2015","unstructured":"Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gomez MG, Langois CM, et al. Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred a cross-sectional study. JAMA Neurol. 2015;72(3):316\u201324.","journal-title":"JAMA Neurol"},{"issue":"Suppl 3","key":"765_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3233\/JAD-2011-0059","volume":"26","author":"EM Reiman","year":"2011","unstructured":"Reiman EM, Langbaum JB, Fleisher AS, Caselli RJ, Chen K, Ayutyanont N, et al. Alzheimer\u2019s prevention initiative: a plan to accelerate the evaluation of presymptomatic treatments. J Alzheimers Dis. 2011;26(Suppl 3):321\u20139.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"765_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ana.24546","volume":"79","author":"KA Johnson","year":"2016","unstructured":"Johnson KA, Schultz A, Betensky RA, Becker JA, Sepulcre J, Rentz D, et al. Tau positron emission tomographic imaging in aging and early Alzheimer disease: tau PET in aging and early AD. Ann Neurol. 2016;79(1):110\u20139.","journal-title":"Ann Neurol"},{"issue":"5","key":"765_CR13","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Sch\u00f6ll","year":"2016","unstructured":"Sch\u00f6ll M, Lockhart SN, Schonhaut DR, O\u2019Neil JP, Janabi M, Ossenkoppele R, et al. PET imaging of tau deposition in the aging human brain. Neuron. 2016;89(5):971\u201382.","journal-title":"Neuron."},{"key":"765_CR14","doi-asserted-by":"crossref","unstructured":"Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA, et al. Association of amyloid and tau with cognition in preclinical Alzheimer disease: a longitudinal study. Jama N. 2019;76(8):915\u201324.","DOI":"10.1001\/jamaneurol.2019.1424"},{"key":"765_CR15","doi-asserted-by":"crossref","unstructured":"Sanchez JS, Becker JA, Jacobs H, Hanseeuw B, Jiang S, Properzi M, et al. The cortical origin and initial spread of medial temporal tauopathy in Alzheimer\u2019s disease assessed with positron emission tomography. Sci Transl Med. 2021;13:eabc0655.","DOI":"10.1126\/scitranslmed.abc0655"},{"issue":"10","key":"765_CR16","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1093\/brain\/awaa248","volume":"143","author":"CR Jack","year":"2020","unstructured":"Jack CR, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, et al. Predicting future rates of tau accumulation on PET. Brain. 2020;143(10):3136\u201350.","journal-title":"Brain."},{"issue":"11","key":"765_CR17","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol. 2011;70(11):960\u20139.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"765_CR18","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jamaneurol.2017.4907","volume":"75","author":"YT Quiroz","year":"2018","unstructured":"Quiroz YT, Sperling RA, Norton DJ, Baena A, Arboleda-Velasquez JF, Cosio D, et al. Association between amyloid and tau accumulation in young adults with autosomal dominant Alzheimer disease. JAMA Neurol. 2018;75(5):548\u201356.","journal-title":"JAMA Neurol."},{"issue":"4","key":"765_CR19","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/brain\/awz019","volume":"142","author":"BA Gordon","year":"2019","unstructured":"Gordon BA, Blazey TM, Christensen J, Dincer A, Flores S, Keefe S, et al. Tau PET in autosomal dominant Alzheimer\u2019s disease: relationship with cognition, dementia and other biomarkers. Brain. 2019;142(4):1063\u201376.","journal-title":"Brain."},{"issue":"5","key":"765_CR20","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/brain\/awy059","volume":"141","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Wiste HJ, Schwarz CG, Lowe VJ, Senjem ML, Vemuri P, et al. Longitudinal tau PET in ageing and Alzheimer's disease. Brain. 2018;141(5):1517\u201328.","journal-title":"Brain."},{"issue":"2","key":"765_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/ana.25406","volume":"85","author":"TM Harrison","year":"2019","unstructured":"Harrison TM, La Joie R, Maass A, Baker SL, Swinnerton K, Fenton L, et al. Longitudinal tau accumulation and atrophy in aging and Alzheimer disease. Ann Neurol. 2019;85(2):229\u201340.","journal-title":"Ann Neurol"},{"key":"765_CR22","doi-asserted-by":"crossref","unstructured":"Pontecorvo MJ, Devous MD, Kennedy I, Navitsky M, Lu M, Galante N, et al. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia. Brain. 2019;142(6):1723\u201335.","DOI":"10.1093\/brain\/awz090"},{"issue":"3","key":"765_CR23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41593-018-0070-z","volume":"21","author":"HIL Jacobs","year":"2018","unstructured":"Jacobs HIL, Hedden T, Schultz AP, Sepulcre J, Perea RD, Amariglio RE, et al. Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals. Nat Neurosci. 2018;21(3):424\u201331.","journal-title":"Nat Neurosci"},{"key":"765_CR24","doi-asserted-by":"publisher","unstructured":"Cho H, Choi JY, Lee HS, Lee J-H, Ryu YH, Lee MS, et al. Progressive tau accumulation in Alzheimer\u2019s disease: two-year follow-up study. J Nucl Med. 2019. https:\/\/doi.org\/10.2967\/jnumed.118.221697.","DOI":"10.2967\/jnumed.118.221697"},{"issue":"3","key":"765_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/joim.12190","volume":"275","author":"RC Petersen","year":"2014","unstructured":"Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L. Mild cognitive impairment: a concept in evolution. J Intern Med. 2014;275(3):214\u201328.","journal-title":"J Intern Med"},{"issue":"3","key":"765_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S1474-4422(10)70323-9","volume":"10","author":"N Acosta-Baena","year":"2011","unstructured":"Acosta-Baena N, Sepulveda-Falla D, Lopera-G\u00f3mez CM, Jaramillo-Elorza MC, Moreno S, Aguirre-Acevedo DC, et al. Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer\u2019s disease: a retrospective cohort study. Lancet Neurol. 2011;10(3):213\u201320.","journal-title":"Lancet Neurol"},{"issue":"Pt 8","key":"765_CR27","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1093\/brain\/awp123","volume":"132","author":"RS Desikan","year":"2009","unstructured":"Desikan RS, Cabral HJ, Hess CP, Dillon WP, Glastonbury CM, Weiner MW, et al. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain. 2009;132(Pt 8):2048\u201357.","journal-title":"Brain."},{"issue":"11","key":"765_CR28","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1001\/jamaneurol.2014.2031","volume":"71","author":"EC Mormino","year":"2014","unstructured":"Mormino EC, Betensky RA, Hedden T, Schultz AP, Amariglio RE, Rentz DM, et al. Synergistic effect of beta-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurol. 2014;71(11):1379\u201385.","journal-title":"JAMA Neurol."},{"issue":"C","key":"765_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.neuroimage.2013.12.021","volume":"92","author":"DN Greve","year":"2014","unstructured":"Greve DN, Svarer C, Fisher PM, Feng L, Hansen AE, Baare W, et al. Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data. NeuroImage. 2014;92(C):225\u201336.","journal-title":"NeuroImage."},{"issue":"1","key":"765_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC, Benzinger TL, Devous MD Sr, Jagust WJ, et al. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 2015;11(1):1\u201315 e1\u20134.","journal-title":"Alzheimers Dement"},{"issue":"23","key":"765_CR31","doi-asserted-by":"publisher","first-page":"6174","DOI":"10.1523\/JNEUROSCI.0730-07.2007","volume":"27","author":"WE Klunk","year":"2007","unstructured":"Klunk WE, Price JC, Mathis CA, Tsopelas ND, Lopresti BJ, Ziolko SK, et al. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci. 2007;27(23):6174\u201384.","journal-title":"J Neurosci"},{"key":"765_CR32","doi-asserted-by":"crossref","unstructured":"Hanseeuw BJ, Lopera F, Sperling RA, Norton DJ, Guzman-Velez E, Baena A, et al. Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer\u2019s disease. Alz Res Ther. 2019;76(8):915\u201324.","DOI":"10.1186\/s13195-019-0468-1"},{"key":"765_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.neuroimage.2017.07.050","volume":"161","author":"S Mishra","year":"2017","unstructured":"Mishra S, Gordon BA, Su Y, Christensen J, Friedrichsen K, Jackson K, et al. AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: defining a summary measure. NeuroImage. 2017;161:171\u20138.","journal-title":"NeuroImage."},{"issue":"4","key":"765_CR34","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1001\/jamaneurol.2015.4851","volume":"73","author":"DC Aguirre-Acevedo","year":"2016","unstructured":"Aguirre-Acevedo DC, Lopera F, Henao E, Tirado V, Munoz C, Giraldo M, et al. Cognitive decline in a Colombian kindred with autosomal dominant Alzheimer disease: a retrospective cohort study. JAMA Neurol. 2016;73(4):431\u20138.","journal-title":"JAMA Neurol."},{"issue":"8","key":"765_CR35","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","volume":"71","author":"MC Donohue","year":"2014","unstructured":"Donohue MC, Sperling RA, Salmon DP, Rentz DM, Raman R, Thomas RG, et al. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol. 2014;71(8):961\u201370.","journal-title":"JAMA Neurol"},{"key":"765_CR36","doi-asserted-by":"crossref","unstructured":"Guzman-Velez E, Martinez J, Papp K, Baena A, Vila-Castelar C, Artola A, et al. Associative memory and in vivo brain pathology in asymptomatic presenilin-1 E280A carriers. Neruol. 2020;95(10):e1312\u2013e1321.","DOI":"10.1212\/WNL.0000000000010177"},{"key":"765_CR37","volume-title":"WMS-R: Wechsler memory scale\u2014revised","author":"D Wechsler","year":"1987","unstructured":"Wechsler D. WMS-R: Wechsler memory scale\u2014revised. San Antonio: Psychological Corporation; 1987."},{"issue":"3","key":"765_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res"},{"issue":"10","key":"765_CR39","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","volume":"80","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Wiste HJ, Lesnick TG, Weigand SD, Knopman DS, Vemuri P, et al. Brain beta-amyloid load approaches a plateau. Neurology. 2013;80(10):890\u20136.","journal-title":"Neurology."},{"issue":"14","key":"765_CR40","doi-asserted-by":"publisher","first-page":"e1295","DOI":"10.1212\/WNL.0000000000006277","volume":"91","author":"E McDade","year":"2018","unstructured":"McDade E, Wang G, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, et al. Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease. Neurology. 2018;91(14):e1295\u2013e306.","journal-title":"Neurology."},{"issue":"3","key":"765_CR41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","volume":"17","author":"BA Gordon","year":"2018","unstructured":"Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer disease: a longitudinal study. Lancet Neurol. 2018;17(3):241\u201350.","journal-title":"Lancet Neurol"},{"issue":"3","key":"765_CR42","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/brain\/awv404","volume":"139","author":"E Rodriguez-Vieitez","year":"2016","unstructured":"Rodriguez-Vieitez E, Saint-Aubert L, Carter SF, Almkvist O, Farid K, Sch\u00f6ll M, et al. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer\u2019s disease. Brain. 2016;139(3):922\u201336.","journal-title":"Brain."},{"issue":"8","key":"765_CR43","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S1474-4422(15)00135-0","volume":"14","author":"W-YW Yau","year":"2015","unstructured":"Yau W-YW, Tudorascu DL, McDade EM, Ikonomovic S, James JA, Minhas D, et al. Longitudinal change of neuroimaging and clinical markers in autosomal dominant Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 2015;14(8):804\u201313.","journal-title":"Lancet Neurol"},{"issue":"12","key":"765_CR44","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1474-4422(12)70227-2","volume":"11","author":"AS Fleisher","year":"2012","unstructured":"Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gomez MG, Langois CM, et al. Florbetapir PET analysis of amyloid-\u03b2 deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study. Lancet Neurol. 2012;11(12):1057\u201365.","journal-title":"Lancet Neurol"},{"issue":"19","key":"765_CR45","doi-asserted-by":"publisher","first-page":"e1809","DOI":"10.1212\/WNL.0000000000006469","volume":"91","author":"ME Farrell","year":"2018","unstructured":"Farrell ME, Chen X, Rundle MM, Chan MY, Wig GS, Park DC. Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults. Neurology. 2018;91(19):e1809\u2013e21.","journal-title":"Neurology."},{"issue":"11","key":"765_CR46","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41591-019-0611-3","volume":"25","author":"JF Arboleda-Velasquez","year":"2019","unstructured":"Arboleda-Velasquez JF, Lopera F, O'Hare M, Delgado-Tirado S, Marino C, Chmielewska N, et al. Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019;25(11):1680\u20133.","journal-title":"Nat Med"},{"issue":"2","key":"765_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ana.24711","volume":"80","author":"H Cho","year":"2016","unstructured":"Cho H, Choi JY, Hwang MS, Kim YJ, Lee HM, Lee HS, et al. In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum. Ann Neurol. 2016;80(2):247\u201358.","journal-title":"Ann Neurol"},{"issue":"12","key":"765_CR48","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/s41591-018-0206-4","volume":"24","author":"J Sepulcre","year":"2018","unstructured":"Sepulcre J, Grothe MJ, d\u2019Oleire Uquillas F, Ortiz-Ter\u00e1n L, Diez I, Yang H-S, et al. Neurogenetic contributions to amyloid beta and tau spreading in the human cortex. Nat Med. 2018;24(12):1910\u20138.","journal-title":"Nat Med"},{"issue":"2","key":"765_CR49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.25395","volume":"85","author":"RA Sperling","year":"2019","unstructured":"Sperling RA, Mormino EC, Schultz AP, Betensky RA, Papp KV, Amariglio RE, et al. The impact of amyloid-beta and tau on prospective cognitive decline in older individuals. Ann Neurol. 2019;85(2):181\u201393.","journal-title":"Ann Neurol"},{"issue":"226","key":"765_CR50","doi-asserted-by":"publisher","first-page":"226ra30","DOI":"10.1126\/scitranslmed.3007901","volume":"6","author":"AM Fagan","year":"2014","unstructured":"Fagan AM, Xiong C, Jasielec MS, Bateman RJ, Goate AM, Benzinger TLS, et al. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer\u2019s disease. Sci Transl Med. 2014;6(226):226ra30.","journal-title":"Sci Transl Med"},{"issue":"7","key":"765_CR51","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.jalz.2018.01.012","volume":"14","author":"CL Sutphen","year":"2018","unstructured":"Sutphen CL, McCue L, Herries EM, Xiong C, Ladenson JH, Holtzman DM, et al. Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(7):869\u201379.","journal-title":"Alzheimers Dement"},{"issue":"16","key":"765_CR52","doi-asserted-by":"publisher","first-page":"eaaz2387","DOI":"10.1126\/sciadv.aaz2387","volume":"6","author":"N Mattsson-Carlgren","year":"2020","unstructured":"Mattsson-Carlgren N, Andersson E, Janelidze S, Ossenkoppele R, Insel P, Strandberg O, et al. Abeta deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease. Sci Adv. 2020;6(16):eaaz2387.","journal-title":"Sci Adv"},{"issue":"1","key":"765_CR53","doi-asserted-by":"publisher","first-page":"fcz046","DOI":"10.1093\/braincomms\/fcz046","volume":"2","author":"AJ Weigand","year":"2020","unstructured":"Weigand AJ, Bangen KJ, Thomas KR, Delano-Wood L, Gilbert PE, Brickman AM, et al. Is tau in the absence of amyloid on the Alzheimer\u2019s continuum?: A study of discordant PET positivity. Brain Commun. 2020;2(1):fcz046.","journal-title":"Brain Commun"},{"key":"765_CR54","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.49132","volume":"8","author":"JN Adams","year":"2019","unstructured":"Adams JN, Maass A, Harrison TM, Baker SL, Jagust WJ. Cortical tau deposition follows patterns of entorhinal functional connectivity in aging. eLife. 2019;8:e49132.","journal-title":"eLife."},{"issue":"7","key":"765_CR55","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1093\/brain\/awaa155","volume":"143","author":"I Sintini","year":"2020","unstructured":"Sintini I, Graff-Radford J, Senjem ML, Schwarz CG, Machulda MM, Martin PR, et al. Longitudinal neuroimaging biomarkers differ across Alzheimer\u2019s disease phenotypes. Brain. 2020;143(7):2281\u201394.","journal-title":"Brain."},{"key":"765_CR56","doi-asserted-by":"crossref","unstructured":"Franzmeier N, Dewenter A, Frontzkowski L, Dichgans M, Rubinski A, Neitzel J, et al. Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer\u2019s disease. Sci Adv. 2020;6(48):abd1327.","DOI":"10.1126\/sciadv.abd1327"},{"key":"765_CR57","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.nicl.2016.05.017","volume":"11","author":"CG Schwarz","year":"2016","unstructured":"Schwarz CG, Gunter JL, Wiste HJ, Przybelski SA, Weigand SD, Ward CP, et al. A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer\u2019s disease severity. NeuroImage Clin. 2016;11:802\u201312.","journal-title":"NeuroImage Clin"},{"issue":"1","key":"765_CR58","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3233\/JAD-180749","volume":"67","author":"CG Schwarz","year":"2019","unstructured":"Schwarz CG, Gunter JL, Lowe VJ, Weigand S, Vemuri P, Senjem ML, et al. A comparison of partial volume correction techniques for measuring change in serial amyloid PET SUVR. J Alzheimers Dis. 2019;67(1):181\u201395.","journal-title":"J Alzheimers Dis"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00765-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13195-020-00765-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-020-00765-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T16:41:42Z","timestamp":1697560902000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-020-00765-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["765"],"URL":"https:\/\/doi.org\/10.1186\/s13195-020-00765-5","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,15]]},"assertion":[{"value":"5 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval for this study was obtained from the University of Antioquia (Colombia) Ethics Committee and the Partners Human Research Institutional Review Board (Boston, US). Participants provided written informed consent before enrollment into the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Reiman reports receiving personal fees as a Scientific Advisor to Roche Diagnostics (travel expenses only), MagQ, Avid Radiopharmaceuticals, and is a share-holding co-founder of ALZPath, outside the submitted work. In addition, he is the inventor of a patent issued to Banner Health, which involves the use of biomarker endpoints in at-risk persons to accelerate the evaluation of Alzheimer\u2019s disease prevention therapies and is outside the submitted work. Drs. Reiman and Lopera are principal investigators of the Alzheimer\u2019s Prevention Initiative (API) Autosomal Dominant AD Trial, which is supported by NIA, philanthropy, Genentech, and Roche. Dr. Sperling is a site principal investigator or coinvestigator for Avid, Bristol-Myers Squibb, Pfizer, and Janssen Alzheimer Immunotherapy clinical trials. She receives travel funding and honoraria from AC Immune, Janssen, and Roche. She consults for Biogen, Roche, AC Immune, Eisai, Takeda, Neurocentria, and Janssen. Spouse consults for Novartis, AC Immune, and Janssen. Dr. Johnson has provided consulting services for Novartis, Biogen, and Eli Lilly. All other co-authors have no competing interests or disclosures relevant to the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}